Please login to the form below

Not currently logged in
Email:
Password:

Aerocrine

This page shows the latest Aerocrine news and features for those working in and with pharma, biotech and healthcare.

Circassia slumps as cat allergy vaccine fails late-stage trial

Circassia slumps as cat allergy vaccine fails late-stage trial

drugs and novel combinations gained through its acquisitions of Aerocrine and Prosonix last year.

Latest news

  • Allergy specialist Circassia buys asthma firms Allergy specialist Circassia buys asthma firms

    Circassia will pay £139m ($219m) for Aerocrine and up to £100m for Prosonix. ... Circassia will use Aerocrine's established commercial operation to help with the launch of its new cat allergy treatment Cat-SPIRE.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics